Kun-Lin Liu

发表

Identification of a new series of benzothiazinone derivatives with excellent antitubercular activity and improved pharmacokinetic profiles

Yuquan Wei, Q. Lei, Ningyu Wang, 2018 .

Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis

Yuquan Wei, Lidan Zhang, Yongxia Zhu, 2016, Scientific Reports.

Neo-5,22E-Cholestadienol Derivatives from Buthus martensii Karsch and Targeted Bactericidal Action Mechanisms

Huaqing Liu, Kun-Lin Liu, Qiangqiang Yang, 2018, Molecules.

Design, synthesis and biological evaluation of 3,5-dimethylisoxazole and pyridone derivatives as BRD4 inhibitors.

Ningyu Wang, Ying Xu, Luoting Yu, 2019, Bioorganic & medicinal chemistry letters.

Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing.

Theodore A. Martinot, Yongxin Han, N. Solban, 2022, Journal of medicinal chemistry.

Quantitative Proteomics Explore the Potential Targets and Action Mechanisms of Hydroxychloroquine

Hong Liu, Yue-lu Jiang, Zhiqiang Zhao, 2022, Molecules.

Purification and Properties of a Novel Insecticidal Protein from the Locust Pathogen Serratia marcescens HR-3

Y. Tao, Ke Tao, Kun-Lin Liu, 2005, Current Microbiology.

Discovery of quinolone derivatives as antimycobacterial agents

Luoting Yu, L. Xiong, Chao Gao, 2021, RSC advances.

Identification of a new series of benzothiazinone derivatives with excellent antitubercular activity and improved pharmacokinetic profiles

Yuquan Wei, Q. Lei, Ningyu Wang, 2018, RSC advances.

Discovery and evaluation of novel nitrodihydroimidazooxazoles as promising anti-tuberculosis agents.

Chao Gao, Xin Tao, W. Luo, 2019, Bioorganic & medicinal chemistry letters.

Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals

Ningyu Wang, Juan Rong, Xin Tao, 2018, Antimicrobial Agents and Chemotherapy.